These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24837088)
1. Drug promotion tactics-yet another pharma deception? Tagore A Int J Clin Pract; 2014 Jun; 68(6):662-5. PubMed ID: 24837088 [TBL] [Abstract][Full Text] [Related]
2. Clarifying the costs of conflicts of interest. Mayes C; Lipworth W; Kerridge I Int J Clin Pract; 2015 Mar; 69(3):384-5. PubMed ID: 25727803 [No Abstract] [Full Text] [Related]
3. Response to clarifying the costs of conflicts of interest. Stossel TP; Barton DW; Stell LK Int J Clin Pract; 2015 Mar; 69(3):385-6. PubMed ID: 25727804 [No Abstract] [Full Text] [Related]
4. Pharmaism: a tale of two perspectives. Citrome L; Karagianis J; Maguire GA; Nierenberg AA Int J Clin Pract; 2014 Jun; 68(6):659-61. PubMed ID: 24837087 [No Abstract] [Full Text] [Related]
5. After 20 years, industry critics bury skeptics, despite empirical vacuum. Barton D; Stossel T; Stell L Int J Clin Pract; 2014 Jun; 68(6):666-73. PubMed ID: 24837089 [TBL] [Abstract][Full Text] [Related]
6. [Conflicts of interest in the medical profession]. Altisent R; Delgado-Marroquín MT; Astier-Peña MP Aten Primaria; 2019 Oct; 51(8):506-511. PubMed ID: 31248656 [TBL] [Abstract][Full Text] [Related]
7. [Conflicts of interest, an insidious blight on medicine]. Altisent R Aten Primaria; 2019 Oct; 51(8):469-470. PubMed ID: 31202475 [No Abstract] [Full Text] [Related]
8. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias. Brown JL Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801 [No Abstract] [Full Text] [Related]
9. No more free lunches. Abbasi K; Smith R BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587 [No Abstract] [Full Text] [Related]
10. Pharmaceutical companies and medical practitioners or "the beast and the beauty"? Villalba L Clin Dermatol; 2019; 37(1):16-20. PubMed ID: 30554617 [TBL] [Abstract][Full Text] [Related]
12. Defensive medicine: Sword of Damocles. Dudeja S; Dhirar N Natl Med J India; 2018; 31(6):364-365. PubMed ID: 31397373 [TBL] [Abstract][Full Text] [Related]
13. Mixing Dinner and Drugs-Is It Ethically Contraindicated? Essi DF AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881 [No Abstract] [Full Text] [Related]
14. Whose practice is this anyway? To conform or not to conform. Awan S; Grant-Kels JM; Graff J J Am Acad Dermatol; 2016 Dec; 75(6):1271-1273. PubMed ID: 27846958 [No Abstract] [Full Text] [Related]
15. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution? Insel TR JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407 [No Abstract] [Full Text] [Related]
16. Financial incentives and the prescription of newer vaccines by doctors in India. Lodha R; Bhargava A Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294 [No Abstract] [Full Text] [Related]
17. Take this medicine: the legality of prescription incentive schemes. Fanning J; Glover-Thomas N Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438 [No Abstract] [Full Text] [Related]
18. Should physicians rely on pharmaceutical detailing for their education? van Schalkwyk JM; Turner MJ J Clin Hypertens (Greenwich); 2013 Mar; 15(3):218. PubMed ID: 23458597 [No Abstract] [Full Text] [Related]
19. Double standards in clinical practice ethics. Harris IA; Naylor JM Med J Aust; 2014 Feb; 200(2):76. PubMed ID: 24484092 [No Abstract] [Full Text] [Related]
20. Industry relationships with physicians under scrutiny. Beller GA J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446 [No Abstract] [Full Text] [Related] [Next] [New Search]